Skip to main content
Clinical Trials/JPRN-UMIN000038952
JPRN-UMIN000038952
Recruiting
未知

Intravenous immunoglobulin or intralipid treatment for recurrent pregnancy loss or implantation failures women with NK cell abnormality - IVIG or intralipid treatment for RPL or IF women with NK cell abnormality

Hyogo College of Medicine0 sites100 target enrollmentDecember 24, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Recurrent pregnancy loss, implantation failure
Sponsor
Hyogo College of Medicine
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 24, 2019
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Untreated other causes of infertility or RPL Allergy for IVIG or intralipid

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The No IntraCranial Haemorrhage (NOICH) StudyFoetal or neonatal alloimmune thrombocytopeniaPregnancy and ChildbirthOther perinatal haematological disorders
ISRCTN29462550eiden University Medical Centre (LUMC) (Netherlands)212
Not yet recruiting
Not Applicable
Intravenous Immunoglobulin replacement therapy for persistent COVID-19 in patients with B-cell impairment: a multicenter randomized controlled trialCertain infectious and parasitic diseases
KCT0009239Samsung Medical Center58
Completed
Not Applicable
High-dose intravenous immunoglobulin therapy for refractory viral infection after allogeneic hematopoietic stem cell transplantation.
JPRN-UMIN000003034Hematology, Osaka City University, Graduate School of Meicine14
Suspended
Phase 3
Intravenous immunoglobulin and intravenous methylprednisolone as optimal induction treatment in CIDP (OPTIC trial)Chronic Inflammatory Demyelinating PolyneuropathyCIDP10034606
NL-OMON50340Academisch Medisch Centrum60
Active, not recruiting
Phase 1
Initial treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) - combined immunoglobulin and steroid treatment versus immunoglobulin treatment alone.Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)MedDRA version: 21.1Level: PTClassification code 10057645Term: Chronic inflammatory demyelinating polyradiculoneuropathySystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2017-002511-34-GBAcademic Medical Centre, Amsterdam, 96